| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.58 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |